A61K 39/35
Allergens
A61K39/35 (Allergens) appears on 670 US grants and 1,152 published applications in this corpus.
Search patents in A61K- Granted patents
- 670
- Published applications
- 1,152
- Assignees
- 457
- Inventors
- 1,645
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 11 | 0 |
| 1998 | 12 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 9 | 4 |
| 2002 | 8 | 17 |
| 2003 | 11 | 28 |
| 2004 | 9 | 32 |
| 2005 | 2 | 19 |
| 2006 | 13 | 31 |
| 2007 | 9 | 28 |
| 2008 | 5 | 16 |
| 2009 | 12 | 32 |
| 2010 | 12 | 40 |
| 2011 | 9 | 36 |
| 2012 | 11 | 48 |
| 2013 | 22 | 46 |
| 2014 | 23 | 63 |
| 2015 | 30 | 69 |
| 2016 | 47 | 77 |
| 2017 | 38 | 70 |
| 2018 | 43 | 49 |
| 2019 | 31 | 63 |
| 2020 | 35 | 64 |
| 2021 | 44 | 59 |
| 2022 | 37 | 58 |
| 2023 | 32 | 53 |
| 2024 | 19 | 62 |
| 2025 | 22 | 47 |
| 2026 | 29 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Systems and methods for administering dermal and transdermal immunotherapy topical application compounds to animals6 Oct 2026US 12,751,998 B2Allibre Animal LLC
- Method for establishing epicutaneously sensitized food allergy animal model22 Sep 2026US 12,741,020 B2Zhejiang Gongshang University
- Compositions and methods for inducing immune tolerance8 Sep 2026US 12,728,155 B2Anokion SA
- Method for classifying an allergic patient as eligible to allergen immunotherapy8 Sep 2026US 12,730,114 B2Stallergenes Greer International AG
- Methods for preventing an immunoglobulin e-related disease25 Aug 2026US 12,714,736 B2My-Or Diagnostics Ltd.
- Treatment of peanut allergy with tolerizing nanoparticles8 Oct 2026US 2026/0306622 A1Cour Pharmaceuticals Development Company, Inc.
- Vaccine for treating allergies1 Oct 2026US 2026/0295036 A1Worg Pharmaceuticals (Zhejiang) Co., Ltd.
- Microbial consortium and uses thereof24 Sep 2026US 2026/0284125 A1The Regents of the University of California
- Therapeutic food products for food allergy treatment24 Sep 2026US 2026/0284182 A1
- Therapeutic food products for food allergy treatment24 Sep 2026US 2026/0284183 A1
Most cited
By later US patents
- Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof212US 6,589,940 B1Dynavax Technologies Corporation · 2003
- Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides190US 5,679,647 AThe Regents of the University of California · 1997
- Immunostimulatory polynucleotide/immunomodulatory molecule conjugates162US 6,610,661 B1The Regents of the University of California · 2003
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- Method for treating allergic lung disease110US 5,849,719 AThe Regents of the University of California · 1998